Montréal - Quebec | Canada
| Investor Type | Firm |
| Stages | Series A, Series B |
| Investing | Canada |
| Investment Range | $14,000,000 - $57,000,000 |
What is Amorchem?
AmorChem l.p., our fourth focused fund, was launched in 2011 to increase the commercial potential of the quality academic research carried out in Quebec. AmorChem is focused on investing in promising life science projects originating from Québec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept in a semi-virtual mode. AmorChem will generate returns through a two-pronged exit strategy:
What are the investment firms similar to Amorchem
GeneChem (closed)
Khosla Ventures
Davidson Technology Growth Debt Fund
Ideavelopers
Algebra Ventures
Calm/Storm VC
QF Capital
Alate Partners
Eastern Bell Venture Capital
Veepee
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 71-75 Shelton Street, Covent Garden, WC2H 9JQ
- London, U.K.
- contact@angelspartners.com
